Dian Diagnostics Group Co.,Ltd.

XSEC:300244 Stock Report

Market Cap: CN¥7.6b

Dian Diagnostics GroupLtd Past Earnings Performance

Past criteria checks 0/6

Dian Diagnostics GroupLtd's earnings have been declining at an average annual rate of -12.9%, while the Healthcare industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 11.1% per year.

Key information

-12.9%

Earnings growth rate

-13.0%

EPS growth rate

Healthcare Industry Growth7.0%
Revenue growth rate11.1%
Return on equity1.0%
Net Margin-0.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Dian Diagnostics GroupLtd makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

XSEC:300244 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2412,374-932,563337
30 Jun 2412,785-742,590370
31 Mar 2413,1501702,623405
31 Dec 2313,4083072,676433
30 Sep 2314,945-4632,660475
30 Jun 2316,37182,777565
31 Mar 2318,8658412,913623
01 Jan 2320,2821,4343,122638
30 Sep 2219,3742,3583,233626
30 Jun 2218,0452,3163,068547
31 Mar 2214,8631,5782,675464
01 Jan 2213,0831,1632,387425
30 Sep 2112,5151,1362,089402
30 Jun 2111,9671,0291,990359
31 Mar 2111,9851,1351,973348
31 Dec 2010,6498031,795319
30 Sep 209,7168951,584260
30 Jun 208,9326011,516241
31 Mar 208,1502811,441220
31 Dec 198,4533471,451212
30 Sep 198,2914481,507200
30 Jun 198,0064331,476190
31 Mar 197,5933981,404172
31 Dec 186,9673891,288166
30 Sep 186,2143921,182147
30 Jun 185,6403731,006198
31 Mar 185,169356971160
31 Dec 175,004350979127
30 Sep 174,90332591898
30 Jun 174,5153089170
31 Mar 174,2332798620
31 Dec 163,8242637770
30 Sep 163,1472386370
30 Jun 162,6732215580
31 Mar 162,1651884780
31 Dec 151,8581754300
30 Sep 151,6451614060
30 Jun 151,5231513840
31 Mar 151,4111323590
31 Dec 141,3351253400
30 Sep 141,2751133170
30 Jun 141,1781033010
31 Mar 141,082902850
31 Dec 131,015862680

Quality Earnings: 300244 is currently unprofitable.

Growing Profit Margin: 300244 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 300244 is unprofitable, and losses have increased over the past 5 years at a rate of 12.9% per year.

Accelerating Growth: Unable to compare 300244's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 300244 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-5.7%).

Return on Equity

High ROE: 300244 has a negative Return on Equity (0.98%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 09:14
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dian Diagnostics Group Co.,Ltd. is covered by 19 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shuchang LiuChangjiang Securities Co. LTD.
Yolanda YinChina Galaxy International Securities (Hong Kong)
Pei ChengChina Galaxy Securities Co., Ltd.